San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Sommetrics Names Corbet Lancaster Senior VP of Finance

A small medtech company in Vista, Sommetrics, has recruited Corbet “Cory” Lancaster to serve as the company’s new senior vice president of finance.

By Brittany Meiling July 19, 2017 4:44 p.m. share »

Chinese PE Firm Closes $400 Million Fund

A Chinese private equity firm that has its eye on San Diego biotech just closed a $400 million fund, its second and biggest yet.

By Brittany Meiling July 19, 2017 2:18 p.m. share »

Ionis Pharmaceuticals Earns $10 Million Payment From Biogen

Carlsbad drugmaker Ionis Pharmaceuticals Inc. has earned a $10 million paycheck from its big biotech partner Biogen Inc.

By Brittany Meiling July 18, 2017 9:44 a.m. share »
Tease photo

Phoenix Molecular Appoints Chief Scientific Officer

A longtime member of San Diego’s life science community, Dr. Gerrit Los, has been named chief scientific officer at Phoenix Molecular Designs.

By Sarah de Crescenzo July 18, 2017 9:41 a.m. share »

Steve Powell Named CEO of SynteractHCR

San Diego-based contract research organization SynteractHCR Holdings Corp. has hired Steve Powell as its new chief executive officer, replacing Wendel Barr, the firm’s CEO for six years.

By Sarah de Crescenzo July 17, 2017 3:06 p.m. share »

Quidel to Acquire Assets of Alere for $440 Million

Quidel Corp., a diagnostic test maker in San Diego, has a $440 million deal pending to purchase assets from East Coast diagnostic firm Alere Inc.

By Brittany Meiling July 17, 2017 2:56 p.m. share »

A Luminary Named to Connect Entrepreneur Hall of Fame

Connect has named Jay Flatley of Illumina as its 2017 inductee to the Connect Entrepreneur Hall of Fame.

By Brad Graves July 16, 2017 1 p.m. share »

TrovaGene Inc.'s Share Price Falls Following Stock Offering Announcement

The stock price for TrovaGene Inc. was down over 20 percent by close of market July 14, following the company’s announcement that it would raise $7.1 million in a stock offering.

By Brittany Meiling July 14, 2017 2:17 p.m. share »

Ionis Pharmaceuticals' Valuation Climbs 40 Percent in Q2

Carlsbad drugmaker Ionis Pharmaceuticals watched its public valuation climb 40 percent during the second quarter of 2017, making it the third-biggest life science company in San Diego.

By Brittany Meiling July 12, 2017 3:57 p.m. share »

New Drug's Potential Lifts Stock of Arena Pharmaceuticals

The stock for local drugmaker Arena Pharmaceuticals Inc. is skyrocketing Tuesday following news that the company may have a promising drug in the labs.

By Brittany Meiling July 11, 2017 2:55 p.m. share »

PURE Bioscience, Roka Bioscience to Combine Marketing Efforts

El Cajon-based PURE Bioscience has partnered with Roka Bioscience in a combined marketing effort, expanding PURE’s reach to Roka’s entire customer base.

By Brittany Meiling July 10, 2017 12:08 p.m. share »

TrovaGene Escapes Delisting From Nasdaq

Local biotech TrovaGene Inc. is back in line with the Nasdaq rules, meaning — for the time being — the company won’t get delisted from the public market.

By Brittany Meiling July 10, 2017 11:59 a.m. share »
Tease photo

Scripps, Qualcomm Prepare ACO Offering

Scripps Health’s recent agreement with Qualcomm Inc. to build and manage a customized medical network represents San Diego’s boldest step yet toward a Medicare-born model that holds health care providers financially accountable for lowering costs and improving care.

By John Cox July 6, 2017 12:44 p.m. share »
Tease photo

FDA Approval Puts Illumina in Clinic

Illumina Inc., the quiet giant making instruments for the world’s scientists, just got the OK from federal regulators to bring its technology out of the laboratory and into the clinic.

By Brittany Meiling July 6, 2017 12:41 p.m. share »

FDA Grants Special Status to Evofem Drug

A product being developed by local biotech Evofem Biosciences has received a high priority classification from regulators, granting the company a number of perks.

By Brittany Meiling July 5, 2017 12:39 p.m. share »